Don’t judge the obese
Most people with clinically severe obesity live and die without the underlying disease having ever been treated, leading global expert in obesity, Professor John...
Two important new updates to diabetes management
Changes to the National Diabetes Services Scheme (NDSS) now allow more people to access the Continuous Glucose Monitoring (CGM) products available under the scheme...
Collaborate to identify and resolve drug-related problems
An Australian study indicates pharmacists should play a larger role in identifying and resolving drug-related problems (DRPs) as part of a collaborative general practice...
PBS listings for cancer, Parkinson’s and motor neurone disease
Since 1 April, medicines crucial to those suffering from cancer, Parkinson’s and motor neurone disease have become available on the Pharmaceutical Benefits Scheme (PBS).
The...
PSA18 maps out the future of pharmacy
PSA18 has wrapped up in Sydney, with the future of pharmacy firmly in sight as PSA presented the Pharmacists in 2023 Discussion Paper, a...
We must embrace change and lead new models of care
Since becoming National President, I have received significant levels of feedback in support of PSA’s development of pharmacists working in general practice.
I have also...
